Edurant
/
Edurant is an antiretroviral medication that belongs to the class of non-nucleoside reverse transcriptase inhibitors (NNRTIs) and is used in the treatment of HIV-1 infection in adults and pediatric patients. It is administered as an oral tablet and is available by prescription only. Patients are advised that Edurant may cause serious side effects, including depression and mood changes, and should not be used in combination with certain medications that can lead to significant drug interactions.
Mechanism of Action
Edurant, which contains the active ingredient rilpivirine, works by blocking the ability of the HIV virus to multiply in the body. Think of it as a lock that prevents the virus from opening the door to new cells, helping to keep the virus under control and allowing the immune system to recover.
Rilpivirine is a non-nucleoside reverse transcriptase inhibitor (NNRTI) that selectively binds to and inhibits the activity of the HIV-1 reverse transcriptase enzyme. By doing so, it prevents the conversion of viral RNA into DNA, a key step in the HIV replication cycle. This inhibition disrupts the viral life cycle, leading to a decrease in viral load in the body.
25
commonly-prescribed
medication.